D
Viatris Inc. VTRS
$15.79 -$0.34-2.11% NASDAQ
Recommendation
Dividend Power Score
Prev Close
$16.13
Volume
11,457,825
Avg Vol (90D)
8,726,126
Market Cap
$18.58B
Dividend & Yield
$0.48(2.98%)
52-Week Range
$6.85 - $16.18
P/E (TTM)
--
EPS (TTM)
-$3.10
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
Viatris (VTRS) Shares Cross 3% Yield Mark
2/12/2026 - Dividend Channel
Notable ETF Outflow Detected - SPYD, VTRS, AMCR, DOW
2/12/2026 - ETF Channel
A Look At Viatris (VTRS) Valuation After UBS Upgrade And Raised Price Target
2/12/2026 - Simply Wall St
Viatris price target raised by $2 at JPMorgan
2/11/2026 - The Fly
Where is Viatris Inc. (VTRS) Headed According to the Street?
2/10/2026 - Yahoo! Finance: News
Where is Viatris Inc. (VTRS) Headed According to the Street?
2/10/2026 - Insider Monkey
Should WisdomTree U.S. MidCap ETF (EZM) Be on Your Investing Radar?
2/10/2026 - Zacks Investment Research
Why Viatris (VTRS) Stock Is Up Today
2/9/2026 - StockStory Articles
Viatris gains as UBS upgrades to Buy on outlook and pipeline
2/9/2026 - SeekingAlpha.com: All News
Viatris gains as UBS upgrades to Buy on outlook and pipeline
2/9/2026 - Seeking Alpha - Healthcare
12 Best Healthcare Stocks Under $50 to Invest In
2/9/2026 - Insider Monkey
Viatris upgraded to Buy from Neutral at UBS
2/9/2026 - TipRanks Financial Blog
Viatris just upgraded at UBS, here's why
2/9/2026 - The Fly
Is Viatris' New Deal-Tested CLO a Turning Point in Its Transformation Strategy (VTRS)?
2/6/2026 - Simply Wall St
Is It Time To Reassess Viatris (VTRS) After Its Recent Share Price Strength
2/5/2026 - Simply Wall St
3 Unprofitable Stocks with Questionable Fundamentals
2/4/2026 - StockStory Articles
Viatris to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026, and Host Investor Event on March 19, 2026
2/3/2026 - PR Newswire
Mapi Pharma to Present New Safety and Efficacy Data from Glatiramer Acetate Depot Long-Acting Injection Phase II Study in Patients with Primary Progressive Multiple Sclerosis (PPMS) at ACTRIMS Forum 2026
2/3/2026 - Globe Newswire
Viatris appoints Matthew Maletta as Chief Legal Officer
2/3/2026 - The Fly
Viatris Appoints Matthew J. Maletta as Chief Legal Officer
2/3/2026 - PR Newswire
Viatris (VTRS, $13.68) RSI Indicator left the overbought zone on February 02, 2026
2/3/2026 - Tickeron - Stocks
Viatris (VTRS) Valuation Check As Inpefa UAE Launch Extends Its Cardiovascular Growth Story
2/3/2026 - Simply Wall St
Should State Street SPDR Portfolio S&P 500 High Dividend ETF (SPYD) Be on Your Investing Radar?
2/2/2026 - Zacks Investment Research
7 Best Fast Growing Penny Stocks to Buy According to Analysts
1/30/2026 - Insider Monkey
What Does the Market Think About Viatris Inc?
1/29/2026 - Benzinga
Income Statement
Total Revenue (TTM)
$14.12B
EBITDA (TTM)
$3.99B
EBIT (TTM)
$1.40B
Net Income (TTM)
-$3.69B
Balance Sheet
Total Assets (Q)
$37.92B
Total Debt (Q)
$14.77B
Total Liabilities (Q)
$22.70B
Book Value Per Share (Q)
$13.13
Cash Flow
Cash from Operations (TTM)
$1.98B
Cash from Investing (TTM)
-$385.20M
Cash from Financing (TTM)
-$2.48B
Net Change in Cash (TTM)
-$876.60M
Filings
Filing Date
Thursday, November 6, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Loading...
Beta
1.01
7-Day Total Return
15.42%
30-Day Total Return
25.92%
60-Day Total Return
49.01%
90-Day Total Return
56.76%
Year to Date Total Return
26.73%
1-Year Total Return
56.54%
2-Year Total Return
44.55%
3-Year Total Return
51.24%
5-Year Total Return
5.91%
52-week Low
Apr 10, 2025 - $6.85
52-week High
Feb 11, 2026 - $16.18
Valuation
Market Cap
$18.58B - Large Cap
Enterprise Value
$32.19B
Price/Sales (TTM)
1.33
Price/Book (Q)
1.23
Dividends and Shares
Shares Outstanding
1.16B
Dividend Per Share (Most Recent)
$0.12
Dividend Per Share (TTM)
$0.48
Corporate Info
Website
www.viatris.com
Phone Number
724 514 1800
Address
Robert J. Coury Global Center
Canonsburg, PA 15317
Country
United States
Year Founded
1961
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin... more
NASDAQ 02/12/2026 4:00PM Eastern Quotes delayed